In this case, NK cells activated with IL-2 and the TDK peptide (derived from Hsp-70) displayed a more potent cytolytic effect against GBM cells (GL261) and other tumors in vitro when associated with an anti-PD1 antibody. This evidence concerns the gene IL2 and glioblastoma.